Category: Research
-
Experience research into brain tumours hands-on
Our 2017 Lab Experience is now open! Are you aged 16-17 and interested in lab research? If so, we’d love to hear from you.
-
New breakthrough into Medulloblastoma
Researchers from St. Jude Children’s Research Hospital in the US and the German Cancer Research Centre have discovered faulty genes underlying medulloblastoma brain tumours.
-
The Samantha Dickson Brain Cancer Unit discover brain mechanism that could target future therapies
The group of researchers at UCL, funded by The Charity are led by Professor Paolo Salomoni and have discovered that cells are capable of migrating through tissues in the body
-
Researchers find that ultrasound may help get drugs across the blood-brain barrier
This promising technique was developed by Researchers from the University of Oxford, UK and the University of Twente, Netherlands
-
Call for routine DNA test to be offered to all cancer patients
The annual report by Prof Dame Sally Davies says that the genomic plan should be implemented within 5 years in the NHS
-
5-ALA gets FDA approval
The United States’ Food and Drug Administration (FDA) has approved the use of aminolevulinic acid hydrochloride as an optical imaging agent for use in people affected by high grade gliomas.
-
Researchers develop a probe that helps detect cancers cells with almost 100% accuracy
A probe that was first developed by researchers in Canada in 2015 has since been perfected by the team
-
Launching The Everest Centre for research into childhood brain tumours
A groundbreaking international centre for research into childhood brain tumours will be launched today (June 27) in London
-
Scientists have discovered that a lack of ‘editing’ could be driving the most aggressive brain tumours
A new study from the CSIR-Institute of Genomics and Integrative Biology in India examined the mechanism of gene expression within brain tumours and found a lack of microRNA editing
-
Scientists have discovered a protein that could potentially predict glioblastoma outcomes
Scientists from the Cancer Science Institute of Singapore at the National University of Singapore have discovered that the protein BCL6 could potentially be used as a marker to predict the clinical outcome of patients with glioblastoma
-
Researchers from the University of Ohio have found changes in blood that are detectable five years before the diagnosis of brain cancer
A study conducted by Judith Schwartzbaum from the University of Ohio has found that changes in the immune systems appear to signal brain cancer 5 years before symptoms arise
-
Scientists discover enzyme that supports brain tumour growth
Researchers from the University of Texas MD Anderson have discovered an enzyme that helps brain tumours grow in nutrient-starved environments
-
Could the Zika virus be used to treat glioblastomas?
The University of Cambridge is to begins trials using the Zika virus on glioblastoma, the most common and aggressive form of brain tumour. Glioblastomas affect 2,200 people in the UK each year
-
New insight into medulloblastoma
The most common type of malignant childhood brain cancer has been identified as seven separate conditions each needing a different treatment, new research has revealed.
-
We are co-funding Marie Curie’s call to address gaps in palliative and end of life care research
The terminal illness charity is looking for applications that address its key research priorities identified by carers, health and social care professionals and people with terminal illness, and particularly, those areas that have until now received the least attention
-
UK research into the use of cannabidiol to treat brain tumours
Researchers from the Nottingham University’s children’s brain tumour centre are now looking into the effects of cannabidiol (CBD), the non-psychoactive ingredient in marijuana
-
Immunotherapy drug shows lack of promise in Phase 3 clinical trial for glioblastoma patients
Last week Bristol-Myers Squibb announced the initial results from their Phase 3 clinical trial that was assessing the effectiveness and safety of the immunotherapy drug Nivolumab in patients with recurrent glioblastoma.
-
Encouraging results for new clinical approach to glioblastoma treatments
Researchers at McGill University Health Centre (MUHC), Montreal have developed a new clinical approach to enhance the efficiency of treatment for glioblastomas, which increased the average survival time to 22 months.
-
Gene-editing techniques give new insight on key protein involved in medulloblastoma development
Researchers at St. Jude Children’s Research Hospital, USA have revealed how a key protein involved in driving the growth of the most aggressive form of medulloblastoma also plays a role in stopping its development.
-
Pioneering research reveals new genetic errors that lead to an inherited risk of developing glioma
Scientists from The Institute of Cancer Research (ICR) have discovered 13 new genetic errors related with an increased risk of developing glioma in one of the largest ever studies of this devastating disease
-
New research uncovers a molecule that halts DIPG tumour growth
A team of researchers from Northwestern University, USA have identified a molecule that could be used to inhibit the growth of the most fatal paediatric brain tumour, diffuse pontine intrinsic glioma (DIPG).
-
Recent developments of our Leeds-based research into brain tumour treatment
Dr Thomas Ward, part of the Leeds Institute of Cancer and Pathology research team, is funded by various cancer charities including The Brain Tumour Charity.
-
Convection enhanced delivery of a water insoluble drug shows early promise in targeting high grade brain tumours
Findings from a study published in the International Journal of Nanomedicine have shown for the first time that the drug Panobinostat can be encapsulated in a water soluble molecule and delivered to a brain tumour to destroy high grade glioma cells.
-
Clinical trial using an advanced imaging method could predict sites of glioblastoma tumour progression
A new, promising clinical trial, led by Dr Stephen Price, is opening in the UK to look at how using advanced imaging methods can predict where a glioblastoma tumour is likely to grow back before any treatment is given. This study is the first of its kind to better understand this question.